Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
Campo
N
N
Alvarez
S
S
Borzone
S
S
Caglieris
S
S
Zentilin
P
P
Testa
R
R
D000328:Adult; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D006526:Hepatitis C / Q000378:metabolism*; D006521:Hepatitis, Chronic / Q000378:metabolism*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000378:metabolism; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009853:Omeprazole / Q000494:pharmacology* / Q000627:therapeutic use
D008012:Lidocaine; C001173:monoethylglycinexylidide; D006899:Mixed Function Oxygenases; D009853:Omeprazole